William Plovanic
Stock Analyst at Canaccord Genuity
(3.25)
# 1,054
Out of 5,149 analysts
176
Total ratings
41.14%
Success rate
4.22%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Buy | $212 → $198 | $125.85 | +57.33% | 14 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $450 → $435 | $241.84 | +79.87% | 8 | Feb 19, 2026 | |
| ATRC AtriCure | Maintains: Buy | $64 → $53 | $31.46 | +68.47% | 13 | Feb 18, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $112 → $109 | $73.85 | +47.60% | 15 | Feb 17, 2026 | |
| DXCM DexCom | Maintains: Buy | $99 → $95 | $73.08 | +29.99% | 10 | Feb 13, 2026 | |
| CVRX CVRx, Inc. | Maintains: Buy | $11 → $10 | $8.18 | +22.25% | 10 | Feb 13, 2026 | |
| AORT Artivion | Maintains: Buy | $51 → $48 | $38.62 | +24.29% | 5 | Feb 13, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 → $35 | $23.74 | +47.43% | 7 | Dec 17, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $147 → $148 | $148.00 | - | 9 | Dec 17, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 → $12 | $4.94 | +142.91% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $89 → $87 | $85.28 | +2.02% | 30 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $30 | $17.54 | +71.04% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 → $40 | $23.87 | +67.57% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $11.04 | +63.04% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.27 | +451.18% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $91.70 | -1.85% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $97.97 | +3.09% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $8.74 | +71.62% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $340.16 | -16.51% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $13.02 | +92.01% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.53 | +684.31% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $74.85 | -6.48% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $18.92 | +153.70% | 5 | Aug 3, 2023 |
iRhythm Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $212 → $198
Current: $125.85
Upside: +57.33%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $450 → $435
Current: $241.84
Upside: +79.87%
AtriCure
Feb 18, 2026
Maintains: Buy
Price Target: $64 → $53
Current: $31.46
Upside: +68.47%
Boston Scientific
Feb 17, 2026
Maintains: Buy
Price Target: $112 → $109
Current: $73.85
Upside: +47.60%
DexCom
Feb 13, 2026
Maintains: Buy
Price Target: $99 → $95
Current: $73.08
Upside: +29.99%
CVRx, Inc.
Feb 13, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $8.18
Upside: +22.25%
Artivion
Feb 13, 2026
Maintains: Buy
Price Target: $51 → $48
Current: $38.62
Upside: +24.29%
Tandem Diabetes Care
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $23.74
Upside: +47.43%
TransMedics Group
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $148.00
Upside: -
TriSalus Life Sciences
Dec 17, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $4.94
Upside: +142.91%
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $85.28
Upside: +2.02%
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $17.54
Upside: +71.04%
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $23.87
Upside: +67.57%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $11.04
Upside: +63.04%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.27
Upside: +451.18%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $91.70
Upside: -1.85%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $97.97
Upside: +3.09%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $8.74
Upside: +71.62%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $340.16
Upside: -16.51%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $13.02
Upside: +92.01%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.53
Upside: +684.31%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $74.85
Upside: -6.48%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $18.92
Upside: +153.70%